KIRAN NAQVI to Signal Transduction
This is a "connection" page, showing publications KIRAN NAQVI has written about Signal Transduction.
Connection Strength
0.071
-
Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199. Expert Rev Hematol. 2017 10; 10(10):863-874.
Score: 0.043
-
A potential role of ruxolitinib in leukemia. Expert Opin Investig Drugs. 2011 Aug; 20(8):1159-66.
Score: 0.028